デフォルト表紙
市場調査レポート
商品コード
1436209

消費者直販(DTC)遺伝子検査の世界市場レポート 2024

Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
消費者直販(DTC)遺伝子検査の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

消費者直販(DTC)遺伝子検査の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には16.1%の年間複合成長率(CAGR)で33億2,000万米ドルに成長すると予想されます。予測期間で予想される成長は、検査サービスの拡大、個別化医療との統合、健康・ウェルネス産業との連携、遺伝子調査の進歩、政府の支援と規制などの要因に起因すると考えられます。この期間に予想される主な動向としては、試験の提供とパネルのさらなる拡大、消費者向けの教育的取り組み、規制遵守と監視の強化、ゲノムデータの調査と貢献への焦点、さらには価格引き下げとアクセシビリティの向上に向けた取り組みが挙げられます。

遺伝的伝達能力を持つ病気や障害の発生率の増加は、将来の消費者直販(DTC)遺伝子検査市場の拡大を促進すると予想されます。個人のDNAの突然変異を特徴とする遺伝性疾患には、単一遺伝子疾患、多因子性疾患、および染色体疾患が含まれます。消費者に直接提供する遺伝子検査は、さまざまな遺伝性疾患についての意識を高め、健康状態の予測を容易にし、個人の健康状態、病気のリスク、その他の特性についての個別の洞察を提供する上で重要な役割を果たします。これにより、個人は病気のリスクを軽減するために自分の健康とライフスタイルに関して十分な情報に基づいた決定を下すことができるようになります。たとえば、米国を拠点とするオンライン情報サービスであるMedlinePlusによると、症候群 Aは毎年アメリカ人の約20万人に1人が罹患しており、現在約10万人の子供が症候群 Bに悩まされています。さらに、世界統計によると、2020年には約12,000人が症候群 Cで死亡したことが明らかになりました。、障害 Dは米国人口の約1%が生涯に発症します。さらに、2022年2月の世界保健機関(WHO)のデータによると、出生異常により年間24万人の新生児が生後28日以内に死亡し、さらに17万人の生後1か月から5歳の子どもが心臓などの疾患により死亡していることが示されています。欠陥、神経管欠陥、ダウン症候群など。その結果、遺伝的に伝染する病気や障害の蔓延が消費者直販(DTC)遺伝子検査市場の成長を推進しています。

デジタルヘルスソリューションの予想される拡大は、予見可能な将来において消費者直販(DTC)遺伝子検査市場の成長を促進することになるでしょう。デジタルヘルスはテクノロジーを活用してヘルスケアを強化し、患者の転帰を改善し、プロセスを合理化し、個人の健康管理を支援します。 DTC遺伝子検査は、消費者を積極的に関与させ、遺伝子データを統合してパーソナライズし、遠隔医療サービスを促進し、ウェアラブルデバイスと接続し、予防医療を提唱することにより、このデジタルヘルスの成長において極めて重要な役割を果たしています。この傾向の一例は、米国に本拠を置く専門組織である米国医師協会の2022年 9月の報告書で強調されています。この報告書では、デジタル医療ツールが患者ケアに有益であると認識している医師の割合が大幅に増加し、2016年の85%から2022年には93%に上昇していることが明らかになりました。さらに、医師が利用するデジタル医療ツールの平均数も、その結果、デジタルヘルスソリューションの急増が消費者直販(DTC)遺伝子検査市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の消費者直販(DTC)遺伝子検査市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • キャリアテスト
  • 予測テスト
  • 祖先と関係の検査
  • ニュートリゲノム検査
  • その他のタイプ
  • 世界の消費者直販(DTC)遺伝子検査市場、サンプル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 唾液
  • 尿
  • 血液
  • 世界の消費者直販(DTC)遺伝子検査市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 一塩基多型チップ
  • 全ゲノム配列決定
  • ターゲット分析
  • 世界の消費者直販(DTC)遺伝子検査市場、ビジネスモデル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 健康計画モデル
  • 包括的なゲノム検査モデル
  • 医療用精密検査モデル
  • 制限付き特性検査モード
  • 世界の消費者直販(DTC)遺伝子検査市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ラボ
  • 血液銀行
  • 養護施設
  • 病院
  • 画像センター
  • 在宅ケア
  • 化粧品
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の消費者直販(DTC)遺伝子検査市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の消費者直販(DTC)遺伝子検査市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 消費者直販(DTC)遺伝子検査市場の競合情勢
  • 消費者直販(DTC)遺伝子検査市場の企業プロファイル
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Konica Minolta, Inc.
    • Genesis HealthCare, Inc.
    • Ancestry.com LLC

第31章 その他の大手および革新的な企業

  • Myriad Genetics, Inc.
  • Fulgent Genetics, Inc.
  • Sonora Quest Laboratories LLC
  • Prenetics Limited
  • 23andMe Holding Co.
  • Color Health Inc.
  • Living DNA Limited
  • MyHeritage Ltd.
  • Victorian Clinical Genetics Services
  • Dante Labs Srl
  • Helix OpCo LLC
  • Gene by Gene, Ltd.
  • Gene by Gene, Ltd.
  • EasyDNA Ltd.
  • Pathway Genomics Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r15534

Direct-to-consumer genetic testing involves marketing genetic tests directly to consumers through various media channels such as radio, television, print adverts, and the internet. Customers can purchase these tests through online marketplaces and pharmacies. After acquiring a test kit, clients provide a DNA sample, gaining access to their genetic data without the need for a healthcare professional or health insurance provider. Results are typically accessed via a secure website, app, or a written report.

Direct-to-consumer (DTC) genetic testing encompasses various types, including carrier testing, predictive testing, ancestry and relationship testing, nutrigenomic testing, and other variants. Carrier screening assesses whether a person carries genetic alterations for specific disorders. These tests analyze saliva, urine, and blood samples using technologies such as single nucleotide polymorphism chips, whole genome sequencing, and targeted analysis. DTC genetic testing operates under different business models such as health planning, comprehensive genome tests, medical precision tests, and restricted trait tests. End-users of these tests include laboratories, blood banks, nursing homes, hospitals, imaging centers, home care, cosmetics, and other sectors.

The direct-to-consumer (DTC) genetic testing market research report is one of a series of new reports from The Business Research Company that provides direct-to-consumer (DTC) genetic testing market statistics, including direct-to-consumer (DTC) genetic testing industry global market size, regional shares, competitors with a direct-to-consumer (DTC) genetic testing market share, detailed direct-to-consumer (DTC) genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the direct-to-consumer (DTC) genetic testing industry. This direct-to-consumer (DTC) genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The direct-to-consumer (dtc) genetic testing market size has grown rapidly in recent years. It will grow from $1.57 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 16.6%. The growth observed in the historic period can be attributed to factors such as a growing curiosity about ancestry and heritage, trends in health and wellness, effective marketing and consumer education, concerns related to privacy and control over genetic data, and the increasing affordability and accessibility of genetic testing.

The direct-to-consumer (dtc) genetic testing market size is expected to see rapid growth in the next few years. It will grow to $3.32 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%. The anticipated growth in the forecast period can be attributed to factors such as the expansion of test offerings, integration with personalized medicine, collaborations with health and wellness industries, advancements in genetic research, and government support and regulations. Major trends expected in this period include the further expansion of test offerings and panels, educational initiatives for consumers, increased regulatory compliance and oversight, a focus on genomic data research and contributions, as well as efforts towards price reduction and enhanced accessibility.

The increasing incidence of diseases and disorders with genetic transmission capabilities is anticipated to fuel the expansion of the direct-to-consumer (DTC) genetic testing market in the future. Genetic disorders, characterized by mutations in an individual's DNA, encompass single-gene, multifactorial, and chromosomal disorders. Direct-to-consumer genetic testing plays a crucial role in raising awareness about various genetic disorders, facilitating predictions about health, and offering personalized insights into an individual's health, disease risks, and other traits. This, in turn, empowers individuals to make informed decisions regarding their health and lifestyle to mitigate disease risks. For example, as per MedlinePlus, a US-based online information service, syndrome A affects approximately 1 in 200,000 Americans annually, with around 100,000 children currently afflicted by syndrome B. Additionally, global statistics reveal that roughly 12,000 individuals succumbed to syndrome C in 2020, and disorder D develops in approximately 1% of the US population during their lifetimes. Furthermore, data from the World Health Organization (WHO) in February 2022 indicate that birth abnormalities lead to the annual demise of 240,000 newborns within the first 28 days of life and an extra 170,000 children aged 1 month to 5 years due to conditions such as heart defects, neural tube defects, and Down syndrome. Consequently, the escalating prevalence of genetically transmissible diseases and disorders is propelling the growth of the direct-to-consumer (DTC) genetic testing market.

The anticipated expansion of digital health solutions is set to drive the growth of the direct-to-consumer (DTC) genetic testing market in the foreseeable future. Digital health leverages technology to enhance healthcare, improve patient outcomes, streamline processes, and empower individuals in managing their health. DTC genetic testing plays a pivotal role in this digital health growth by actively engaging consumers, integrating genetic data for personalization, facilitating telehealth services, connecting with wearable devices, and advocating for preventive care. An example of this trend is highlighted in a September 2022 report from the American Medical Association, a US-based professional organization. The report reveals a significant increase in the percentage of physicians who perceive digital health tools as beneficial for patient care, rising from 85% in 2016 to 93% in 2022. Furthermore, the average number of digital health tools utilized by physicians has also witnessed a notable growth, increasing from 2.2 in 2016 to 3.8 in 2022. Consequently, the surge in digital health solutions is a driving force behind the growth of the direct-to-consumer (DTC) genetic testing market.

Major players in the direct-to-consumer (DTC) genetic testing market are placing a strategic emphasis on substantial investments in genetic research to maintain their market positions. These investments serve as crucial financial support for genetic testing companies, enabling them to engage in research initiatives, advance technologies, broaden market outreach, ensure regulatory compliance, and foster innovation. As an illustrative example, in November 2022, Redcliffe Labs, an India-based provider of diagnostic services and laboratories, disclosed its intention to allocate an additional $10 million (approximately Rs 81 crore) for the expansion of its genetic and specialized testing portfolio. This financial commitment aims to further enhance the company's capabilities in genetic testing, encompassing areas such as prenatal, oncology, neurology, nephrology, and pharmacogenomics. Notably, Redcliffe Labs has already invested $6 million in the coverage of genetics and specialized testing, emphasizing a forward-looking approach towards next-generation technologies within the diagnostics sector.

Major players in the direct-to-consumer (DTC) genetic testing market are actively engaging in strategic collaborations to fortify their market positions. These strategic partnerships, particularly in the realm of technology-integrated genetic testing, serve to drive innovation, elevate diagnostic capabilities, expand global outreach, ensure adherence to regulatory standards, and propel advancements in personalized medicine. A case in point is the collaboration between Myriad Genetics, a US-based genomic testing company, and Epic Systems, a US-based software company, announced in June 2022. This collaboration focuses on integrating electronic health records (EHR) with genetic testing processes. By seamlessly incorporating Myriad tests into the Epic platform, healthcare providers can efficiently order and review genetic tests, streamlining the overall testing procedure. The integration is designed to improve patient care by delivering crucial genetic insights directly within the electronic health records (EHR) system. Myriad Genetics' strategic emphasis on technology-enabled tools aligns with its growth strategy, with the ultimate goal of enhancing accessibility and efficiency in genetic testing for both patients and clinicians.

In March 2022, LetsGetChecked, a virtual care company based in the United States, specializing in at-home testing, telehealth services, and pharmacy capabilities, successfully acquired Veritas Genetics for an undisclosed sum. This strategic acquisition positions LetsGetChecked to leverage whole-genome sequencing, enabling the initiation of a comprehensive lifecycle of personalized healthcare. The goal is to offer the market an extensive spectrum of health testing and care options. Veritas Genetics, the acquired company, is a biotechnology firm based in the United States, specializing in personal genomics.

Major companies operating in the direct-to-consumer (dtc) genetic testing market report are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Konica Minolta, Inc., Genesis HealthCare, Inc., Ancestry.com LLC, Myriad Genetics, Inc., Fulgent Genetics, Inc., Sonora Quest Laboratories LLC, Prenetics Limited, 23andMe Holding Co., Color Health Inc., Living DNA Limited, MyHeritage Ltd., Victorian Clinical Genetics Services, Dante Labs S.r.l., Helix OpCo LLC, Gene by Gene, Ltd., Gene by Gene, Ltd., EasyDNA Ltd., Pathway Genomics Corporation, Full Genomes Corporation, Identigene LLC, Mapmygenome Labs Pvt. Ltd., Positive Bioscience Inc., Xcode Life Sciences Private Limited, 24Genetics S.L., Direct Laboratory Services, LLC, Karmagenes SA, Request A Test Ltd., Any Lab Test Now, LLC

North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2023. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the direct-to-consumer (dtc) genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The direct-to-consumer (DTC) genetic testing market includes revenues earned by entities by offering DTC genetic kits and services straight to end-customers, that are used in querying patients' DNA information. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on direct-to-consumer (dtc) genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for direct-to-consumer (dtc) genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The direct-to-consumer (dtc) genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Carrier Testing; Predictive Testing; Ancestry And Relationship Testing; Nutrigenomic Testing; Other Types
  • 2) By Sample: Saliva; Urine; Blood
  • 3) By Technology: Single Nucleotide Polymorphism Chips; Whole Genome Sequencing; Targeted Analysis
  • 4) By Business Model: Health Planning Model; Comprehensive Genome Tests Model; Medical Precision Tests Model; Restricted Trait Tests Mode
  • 5) By End User: Laboratories; Blood Banks; Nursing Homes; Hospitals; Imaging Centers; Home Care; Cosmetics; Other End-User
  • Companies Mentioned: Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Konica Minolta, Inc.; Genesis HealthCare, Inc.; Ancestry.com LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Direct-To-Consumer (DTC) Genetic Testing Market Characteristics

3. Direct-To-Consumer (DTC) Genetic Testing Market Trends And Strategies

4. Direct-To-Consumer (DTC) Genetic Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Direct-To-Consumer (DTC) Genetic Testing Market Size and Growth

  • 5.1. Global Direct-To-Consumer (DTC) Genetic Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Direct-To-Consumer (DTC) Genetic Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Direct-To-Consumer (DTC) Genetic Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Direct-To-Consumer (DTC) Genetic Testing Market Segmentation

  • 6.1. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Carrier Testing
  • Predictive Testing
  • Ancestry And Relationship Testing
  • Nutrigenomic Testing
  • Other Types
  • 6.2. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Saliva
  • Urine
  • Blood
  • 6.3. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single Nucleotide Polymorphism Chips
  • Whole Genome Sequencing
  • Targeted Analysis
  • 6.4. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Business Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Health Planning Model
  • Comprehensive Genome Tests Model
  • Medical Precision Tests Model
  • Restricted Trait Tests Mode
  • 6.5. Global Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Laboratories
  • Blood Banks
  • Nursing Homes
  • Hospitals
  • Imaging Centers
  • Home Care
  • Cosmetics
  • Other End-User

7. Direct-To-Consumer (DTC) Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Direct-To-Consumer (DTC) Genetic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Direct-To-Consumer (DTC) Genetic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market

  • 8.1. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Direct-To-Consumer (DTC) Genetic Testing Market

  • 9.1. China Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 9.2. China Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Direct-To-Consumer (DTC) Genetic Testing Market

  • 10.1. India Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Direct-To-Consumer (DTC) Genetic Testing Market

  • 11.1. Japan Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 11.2. Japan Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Direct-To-Consumer (DTC) Genetic Testing Market

  • 12.1. Australia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market

  • 13.1. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Direct-To-Consumer (DTC) Genetic Testing Market

  • 14.1. South Korea Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 14.2. South Korea Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market

  • 15.1. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 15.2. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Direct-To-Consumer (DTC) Genetic Testing Market

  • 16.1. UK Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Direct-To-Consumer (DTC) Genetic Testing Market

  • 17.1. Germany Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Direct-To-Consumer (DTC) Genetic Testing Market

  • 18.1. France Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Direct-To-Consumer (DTC) Genetic Testing Market

  • 19.1. Italy Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Direct-To-Consumer (DTC) Genetic Testing Market

  • 20.1. Spain Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market

  • 21.1. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 21.2. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Direct-To-Consumer (DTC) Genetic Testing Market

  • 22.1. Russia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Direct-To-Consumer (DTC) Genetic Testing Market

  • 23.1. North America Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 23.2. North America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Direct-To-Consumer (DTC) Genetic Testing Market

  • 24.1. USA Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 24.2. USA Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Direct-To-Consumer (DTC) Genetic Testing Market

  • 25.1. Canada Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 25.2. Canada Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Direct-To-Consumer (DTC) Genetic Testing Market

  • 26.1. South America Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 26.2. South America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Direct-To-Consumer (DTC) Genetic Testing Market

  • 27.1. Brazil Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Direct-To-Consumer (DTC) Genetic Testing Market

  • 28.1. Middle East Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 28.2. Middle East Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Direct-To-Consumer (DTC) Genetic Testing Market

  • 29.1. Africa Direct-To-Consumer (DTC) Genetic Testing Market Overview
  • 29.2. Africa Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Direct-To-Consumer (DTC) Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Direct-To-Consumer (DTC) Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Direct-To-Consumer (DTC) Genetic Testing Market Competitive Landscape
  • 30.2. Direct-To-Consumer (DTC) Genetic Testing Market Company Profiles
    • 30.2.1. Laboratory Corporation of America Holdings
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Quest Diagnostics Incorporated
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Konica Minolta, Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Genesis HealthCare, Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Ancestry.com LLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Direct-To-Consumer (DTC) Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Myriad Genetics, Inc.
  • 31.2. Fulgent Genetics, Inc.
  • 31.3. Sonora Quest Laboratories LLC
  • 31.4. Prenetics Limited
  • 31.5. 23andMe Holding Co.
  • 31.6. Color Health Inc.
  • 31.7. Living DNA Limited
  • 31.8. MyHeritage Ltd.
  • 31.9. Victorian Clinical Genetics Services
  • 31.10. Dante Labs S.r.l.
  • 31.11. Helix OpCo LLC
  • 31.12. Gene by Gene, Ltd.
  • 31.13. Gene by Gene, Ltd.
  • 31.14. EasyDNA Ltd.
  • 31.15. Pathway Genomics Corporation

32. Global Direct-To-Consumer (DTC) Genetic Testing Market Competitive Benchmarking

33. Global Direct-To-Consumer (DTC) Genetic Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Direct-To-Consumer (DTC) Genetic Testing Market

35. Direct-To-Consumer (DTC) Genetic Testing Market Future Outlook and Potential Analysis

  • 35.1 Direct-To-Consumer (DTC) Genetic Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Direct-To-Consumer (DTC) Genetic Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Direct-To-Consumer (DTC) Genetic Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer